Illite improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease through Akt/CREB and GSK-3β phosphorylation in the brain

Songhee Jeon, Jeong Eun Park, Jinhee Lee, Quan Feng Liu, Ha Jin Jeong, Sok Cheon Pak, Sudok Yi, Myung Hun Kim, Chan Wha Kim, Jung Keug Park, Geun Woo Kim, Byung Soo Koo

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Ethnopharmacological relevance: The use of illite in Korean medicine has a long history as a therapeutic agent for various cerebrovascular diseases. According to Dongui Bogam, illite can be used for Qi-tonifying, phlegm dispersing and activation of blood circulation which is an important principle for the treatment of brainassociated diseases. Aim of the study: This study was undertaken to evaluate beneficial effects of illite on the neurodegenerative diseases such as Alzheimer's disease (AD). Material and methods: The transgenic mice of AD, Tg-APPswe/PS1dE9, were fed with 1% or 3% of illite for 3 months. Behavioral, immunological and ELISA analyses were used to assess memory impairment with additional measurement of Aβ accumulation and plaque deposition in the brain. Other in vitro studies were performed to examine whether illite inhibits the Ainnodatabeta-induced neurotoxicity in human neuroblastoma cell line, SH-SY5Y cells. Results: Illite treatment rescued Aβ-induced neurotoxicity on SH-SY5Y cells, which was dependent on the PI3K/Akt activation. Intake of illite improved the Aβ-induced memory impairment and suppressed Aβ levels and plaque deposition in the brain of Tg-APPswe/PS1dE9 mice. Illite increased CREB, Akt, and GSK-3β phosphorylation and suppressed tau phosphorylation in the AD-like brains. Moreover, 1% of illite reduced weight gain and suppressed glucose level in the blood. Conclusion: The present study suggests that illite has the potential to be a useful adjunct as a therapeutic drug for the treatment of AD.

Original languageEnglish
Pages (from-to)69-77
Number of pages9
JournalJournal of Ethnopharmacology
Volume160
DOIs
Publication statusPublished - 2015 Feb 3

Fingerprint

Glycogen Synthase Kinase 3
Alzheimer Disease
Phosphorylation
Brain
illite
Qi
Therapeutics
Cerebrovascular Disorders
Blood Circulation
Neuroblastoma
Phosphatidylinositol 3-Kinases
Neurodegenerative Diseases
Transgenic Mice
Weight Gain
History
Enzyme-Linked Immunosorbent Assay
Medicine

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Illite improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease through Akt/CREB and GSK-3β phosphorylation in the brain. / Jeon, Songhee; Park, Jeong Eun; Lee, Jinhee; Liu, Quan Feng; Jeong, Ha Jin; Pak, Sok Cheon; Yi, Sudok; Kim, Myung Hun; Kim, Chan Wha; Park, Jung Keug; Kim, Geun Woo; Koo, Byung Soo.

In: Journal of Ethnopharmacology, Vol. 160, 03.02.2015, p. 69-77.

Research output: Contribution to journalArticle

Jeon, Songhee ; Park, Jeong Eun ; Lee, Jinhee ; Liu, Quan Feng ; Jeong, Ha Jin ; Pak, Sok Cheon ; Yi, Sudok ; Kim, Myung Hun ; Kim, Chan Wha ; Park, Jung Keug ; Kim, Geun Woo ; Koo, Byung Soo. / Illite improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease through Akt/CREB and GSK-3β phosphorylation in the brain. In: Journal of Ethnopharmacology. 2015 ; Vol. 160. pp. 69-77.
@article{b02899bdef514b628ebd649141278214,
title = "Illite improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease through Akt/CREB and GSK-3β phosphorylation in the brain",
abstract = "Ethnopharmacological relevance: The use of illite in Korean medicine has a long history as a therapeutic agent for various cerebrovascular diseases. According to Dongui Bogam, illite can be used for Qi-tonifying, phlegm dispersing and activation of blood circulation which is an important principle for the treatment of brainassociated diseases. Aim of the study: This study was undertaken to evaluate beneficial effects of illite on the neurodegenerative diseases such as Alzheimer's disease (AD). Material and methods: The transgenic mice of AD, Tg-APPswe/PS1dE9, were fed with 1{\%} or 3{\%} of illite for 3 months. Behavioral, immunological and ELISA analyses were used to assess memory impairment with additional measurement of Aβ accumulation and plaque deposition in the brain. Other in vitro studies were performed to examine whether illite inhibits the Ainnodatabeta-induced neurotoxicity in human neuroblastoma cell line, SH-SY5Y cells. Results: Illite treatment rescued Aβ-induced neurotoxicity on SH-SY5Y cells, which was dependent on the PI3K/Akt activation. Intake of illite improved the Aβ-induced memory impairment and suppressed Aβ levels and plaque deposition in the brain of Tg-APPswe/PS1dE9 mice. Illite increased CREB, Akt, and GSK-3β phosphorylation and suppressed tau phosphorylation in the AD-like brains. Moreover, 1{\%} of illite reduced weight gain and suppressed glucose level in the blood. Conclusion: The present study suggests that illite has the potential to be a useful adjunct as a therapeutic drug for the treatment of AD.",
keywords = "Akt, Alzheimer's disease, Beta-amyloid, CREB, Illite, Lithium",
author = "Songhee Jeon and Park, {Jeong Eun} and Jinhee Lee and Liu, {Quan Feng} and Jeong, {Ha Jin} and Pak, {Sok Cheon} and Sudok Yi and Kim, {Myung Hun} and Kim, {Chan Wha} and Park, {Jung Keug} and Kim, {Geun Woo} and Koo, {Byung Soo}",
year = "2015",
month = "2",
day = "3",
doi = "10.1016/j.jep.2014.11.029",
language = "English",
volume = "160",
pages = "69--77",
journal = "Journal of Ethnopharmacology",
issn = "0378-8741",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Illite improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease through Akt/CREB and GSK-3β phosphorylation in the brain

AU - Jeon, Songhee

AU - Park, Jeong Eun

AU - Lee, Jinhee

AU - Liu, Quan Feng

AU - Jeong, Ha Jin

AU - Pak, Sok Cheon

AU - Yi, Sudok

AU - Kim, Myung Hun

AU - Kim, Chan Wha

AU - Park, Jung Keug

AU - Kim, Geun Woo

AU - Koo, Byung Soo

PY - 2015/2/3

Y1 - 2015/2/3

N2 - Ethnopharmacological relevance: The use of illite in Korean medicine has a long history as a therapeutic agent for various cerebrovascular diseases. According to Dongui Bogam, illite can be used for Qi-tonifying, phlegm dispersing and activation of blood circulation which is an important principle for the treatment of brainassociated diseases. Aim of the study: This study was undertaken to evaluate beneficial effects of illite on the neurodegenerative diseases such as Alzheimer's disease (AD). Material and methods: The transgenic mice of AD, Tg-APPswe/PS1dE9, were fed with 1% or 3% of illite for 3 months. Behavioral, immunological and ELISA analyses were used to assess memory impairment with additional measurement of Aβ accumulation and plaque deposition in the brain. Other in vitro studies were performed to examine whether illite inhibits the Ainnodatabeta-induced neurotoxicity in human neuroblastoma cell line, SH-SY5Y cells. Results: Illite treatment rescued Aβ-induced neurotoxicity on SH-SY5Y cells, which was dependent on the PI3K/Akt activation. Intake of illite improved the Aβ-induced memory impairment and suppressed Aβ levels and plaque deposition in the brain of Tg-APPswe/PS1dE9 mice. Illite increased CREB, Akt, and GSK-3β phosphorylation and suppressed tau phosphorylation in the AD-like brains. Moreover, 1% of illite reduced weight gain and suppressed glucose level in the blood. Conclusion: The present study suggests that illite has the potential to be a useful adjunct as a therapeutic drug for the treatment of AD.

AB - Ethnopharmacological relevance: The use of illite in Korean medicine has a long history as a therapeutic agent for various cerebrovascular diseases. According to Dongui Bogam, illite can be used for Qi-tonifying, phlegm dispersing and activation of blood circulation which is an important principle for the treatment of brainassociated diseases. Aim of the study: This study was undertaken to evaluate beneficial effects of illite on the neurodegenerative diseases such as Alzheimer's disease (AD). Material and methods: The transgenic mice of AD, Tg-APPswe/PS1dE9, were fed with 1% or 3% of illite for 3 months. Behavioral, immunological and ELISA analyses were used to assess memory impairment with additional measurement of Aβ accumulation and plaque deposition in the brain. Other in vitro studies were performed to examine whether illite inhibits the Ainnodatabeta-induced neurotoxicity in human neuroblastoma cell line, SH-SY5Y cells. Results: Illite treatment rescued Aβ-induced neurotoxicity on SH-SY5Y cells, which was dependent on the PI3K/Akt activation. Intake of illite improved the Aβ-induced memory impairment and suppressed Aβ levels and plaque deposition in the brain of Tg-APPswe/PS1dE9 mice. Illite increased CREB, Akt, and GSK-3β phosphorylation and suppressed tau phosphorylation in the AD-like brains. Moreover, 1% of illite reduced weight gain and suppressed glucose level in the blood. Conclusion: The present study suggests that illite has the potential to be a useful adjunct as a therapeutic drug for the treatment of AD.

KW - Akt

KW - Alzheimer's disease

KW - Beta-amyloid

KW - CREB

KW - Illite

KW - Lithium

UR - http://www.scopus.com/inward/record.url?scp=84916897116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84916897116&partnerID=8YFLogxK

U2 - 10.1016/j.jep.2014.11.029

DO - 10.1016/j.jep.2014.11.029

M3 - Article

C2 - 25457987

AN - SCOPUS:84916897116

VL - 160

SP - 69

EP - 77

JO - Journal of Ethnopharmacology

JF - Journal of Ethnopharmacology

SN - 0378-8741

ER -